Home > Healthcare > Muscle Stimulation Devices Market
Muscle Stimulation Devices Market Size
Muscle Stimulation Devices Market size is anticipated to register considerable growth over 2024 and 2032, owing to rising prevalence of muscle injuries, chronic pain, and other ailments. As per WHO, nearly 1.71 billion people have musculoskeletal conditions globally. Many sports enthusiasts today are increasingly opting for these devices for rehabilitation to recover from injury.
Recent advancements in electrical muscle stimulation (EMS) technology, enabling more portable and affordable muscle stimulation devices, are driving their increased adoption across various healthcare settings, including homes, hospitals, and clinics.
Muscle Stimulation Devices Market Trends
One significant trend is the integration of wearable technology, enabling users to conveniently incorporate muscle stimulation into their daily routines for fitness and rehabilitation. Additionally, there's a growing emphasis on personalized therapy options, with devices offering customizable settings to cater to individual needs and preferences. The development of wireless connectivity and smartphone compatibility are enhancing the user experience, allowing for seamless control, and monitoring of muscle stimulation sessions.
Muscle Stimulation Devices Market Analysis
The transcutaneous electrical nerve stimulator (TENS) segment is poised to observe substantial gains by 2032, driven by the increasing prevalence of muscle-related sports injuries and chronic pain. Many device manufacturers are coming up with innovative transcutaneous electrical nerve stimulators with advanced technologies which are likely to favour their adoption.
The pain management segment is slated to observe considerable revenue by 2032. Surging instances of chronic pain have proliferated the usage muscle stimulation devices for pain management applications. These devices known for their ability to alleviate pain and promote rehabilitation, are effective in managing various types of pain, including chronic and acute conditions. As healthcare professionals and patients alike seek non-invasive and drug-free alternatives for pain relief, the versatility & efficacy of muscle stimulation devices make them an attractive option.
Europe muscle stimulation devices market is poised to exhibit a notable CAGR through 2032. Rising occurrence of muscle injuries, chronic pain, and other ailments in the region has bolstered the development for muscle stimulation devices. As per credible sources, chronic pain affects nearly 100 million people across Europe, which translates to 1 in every 5 adults. Moreover, increasing elderly population in Europe, which is highly susceptible to chronic pain, create lucrative opportunities for the industry players in the region.
Muscle Stimulation Devices Market Share
The list of leading muscle stimulation devices industry players includes:
- DJO Global Inc. (Colfax Corporation)
- Omron Corporation
- NeuroMetrix Inc
- Axiobionics
Impact of Russia-Ukraine war on muscle stimulation devices industry
The Russia-Ukraine war had a negative impact on healthcare sector due to disruptions in raw material supplies. Both nations have essential raw materials used for manufacturing diagnostic devices. However, geopolitical tensions worsened the important trade links, hampering the industry progress. Despite these issues, governments across the world are putting consolidated efforts towards ending the conflict, which is likely to help revive the economy and bring some recovery to the industry.
Muscle Stimulation Devices Industry News
- In August 2023, EPIC Health, and OMRON Healthcare, collaborated to tackle health inequities and lower the risk of heart attack and stroke in underserved Detroit communities. The program featured VitalSight™, OMRON's inaugural remote patient monitoring service tailored for patients with hypertension.
- In July 2023, Motive Health, a medical technology enterprise, formally launched Motive Knee, its muscle stimulation device approved by the US Food and Drug Administration (FDA). This device offers a non-invasive, non-opioid solution for managing knee pain related to arthritis, aiming to alleviate discomfort effectively.